32540990|t|Nrf2/HO-1 mediates the neuroprotective effects of pramipexole by attenuating oxidative damage and mitochondrial perturbation after traumatic brain injury in rats.
32540990|a|Pramipexole (PPX), a D2-like receptor agonist, is generally used in the treatment of Parkinson's disease and restless leg syndrome. Its neuroprotective effects have been shown against various neurological disorders. Recent research work has demonstrated that PPX exerts neuroprotection through mitochondria. However, the neuromodulator-related effects of PPX against traumatic brain injury (TBI) remain unexplored. The present study, therefore, investigated the mechanism of neuroprotection by PPX against oxidative stress, mitochondrial dysfunction and neuronal damage following TBI in rats. We hypothesized that the neuroprotection by PPX in TBI-subjected rats might involve activation of the Nrf2/HO-1 (also known as Nfe2l2/Hmox1) signaling pathway. PPX was injected intraperitoneally (0.25 mg/kg body weight and 1.0 mg/kg body weight) at different time intervals post-TBI. Several neurobehavioral parameters were assessed at 48 h post-TBI, and the brain was isolated for molecular and biochemical analysis. The results demonstrated that PPX treatment significantly improved the behavioral deficits, decreased the lipid peroxidation rate, increased glutathione levels and decreased 4-hydroxynonenal levels in TBI-subjected rats. PPX also increased the activities of glutathione peroxidase and superoxide dismutase enzymes. In addition, PPX treatment inhibited mitochondrial reactive oxygen species production, restored mitochondrial membrane potential and increased ATP levels after a TBI. Further, PPX treatment reduced the Bax/Bcl2 ratio and translocation of Bax to mitochondria and cytochrome-c to the cytosol. Finally, PPX treatment greatly accelerated the translocation of Nrf2 to the nucleus and upregulated HO-1 protein expression. We conclude that the neuroprotective effects of PPX are mediated by activation of the Nrf2/HO-1 signaling pathway following TBI.This article has an associated First Person interview with the first author of the paper.
32540990	0	4	Nrf2	Gene	83619
32540990	5	9	HO-1	Gene	24451
32540990	50	61	pramipexole	Chemical	MESH:D000077487
32540990	77	86	oxidative	Disease	MESH:D028361
32540990	98	124	mitochondrial perturbation	Disease	MESH:D028361
32540990	131	153	traumatic brain injury	Disease	MESH:D000070642
32540990	157	161	rats	Species	10116
32540990	163	174	Pramipexole	Chemical	MESH:D000077487
32540990	176	179	PPX	Chemical	MESH:D000077487
32540990	248	267	Parkinson's disease	Disease	MESH:D010300
32540990	272	293	restless leg syndrome	Disease	MESH:D012148
32540990	355	377	neurological disorders	Disease	MESH:D009461
32540990	422	425	PPX	Chemical	MESH:D000077487
32540990	518	521	PPX	Chemical	MESH:D000077487
32540990	530	552	traumatic brain injury	Disease	MESH:D000070642
32540990	554	557	TBI	Disease	MESH:D000070642
32540990	657	660	PPX	Chemical	MESH:D000077487
32540990	669	678	oxidative	Disease	MESH:D028361
32540990	687	712	mitochondrial dysfunction	Disease	MESH:D028361
32540990	717	732	neuronal damage	Disease	MESH:D009410
32540990	743	746	TBI	Disease	MESH:D000070642
32540990	750	754	rats	Species	10116
32540990	800	803	PPX	Chemical	MESH:D000077487
32540990	807	810	TBI	Disease	MESH:D000070642
32540990	821	825	rats	Species	10116
32540990	858	862	Nrf2	Gene	83619
32540990	863	867	HO-1	Gene	24451
32540990	883	889	Nfe2l2	Gene	83619
32540990	890	895	Hmox1	Gene	24451
32540990	916	919	PPX	Chemical	MESH:D000077487
32540990	1035	1038	TBI	Disease	MESH:D000070642
32540990	1102	1105	TBI	Disease	MESH:D000070642
32540990	1204	1207	PPX	Chemical	MESH:D000077487
32540990	1245	1264	behavioral deficits	Disease	MESH:D019958
32540990	1280	1285	lipid	Chemical	MESH:D008055
32540990	1315	1326	glutathione	Chemical	MESH:D005978
32540990	1348	1364	4-hydroxynonenal	Chemical	MESH:C027576
32540990	1375	1378	TBI	Disease	MESH:D000070642
32540990	1389	1393	rats	Species	10116
32540990	1395	1398	PPX	Chemical	MESH:D000077487
32540990	1502	1505	PPX	Chemical	MESH:D000077487
32540990	1540	1563	reactive oxygen species	Chemical	MESH:D017382
32540990	1632	1635	ATP	Chemical	MESH:D000255
32540990	1651	1654	TBI	Disease	MESH:D000070642
32540990	1665	1668	PPX	Chemical	MESH:D000077487
32540990	1691	1694	Bax	Gene	24887
32540990	1695	1699	Bcl2	Gene	24224
32540990	1727	1730	Bax	Gene	24887
32540990	1789	1792	PPX	Chemical	MESH:D000077487
32540990	1844	1848	Nrf2	Gene	83619
32540990	1880	1884	HO-1	Gene	24451
32540990	1953	1956	PPX	Chemical	MESH:D000077487
32540990	1991	1995	Nrf2	Gene	83619
32540990	1996	2000	HO-1	Gene	24451
32540990	2029	2037	TBI.This	Disease	MESH:D000070642
32540990	Negative_Correlation	MESH:D000077487	MESH:D019958
32540990	Negative_Correlation	MESH:D000077487	MESH:D012148
32540990	Negative_Correlation	MESH:D000077487	MESH:D028361
32540990	Positive_Correlation	MESH:D000077487	83619
32540990	Negative_Correlation	MESH:D000077487	24887
32540990	Positive_Correlation	MESH:D000077487	MESH:D000255
32540990	Positive_Correlation	MESH:D000077487	MESH:D005978
32540990	Negative_Correlation	MESH:D000077487	MESH:D009410
32540990	Negative_Correlation	MESH:D000077487	MESH:D000070642
32540990	Negative_Correlation	MESH:D000077487	MESH:D010300
32540990	Association	MESH:D000070642	24451
32540990	Association	24451	83619
32540990	Negative_Correlation	MESH:D000077487	24224
32540990	Association	MESH:D028361	83619
32540990	Negative_Correlation	MESH:D000077487	MESH:D008055
32540990	Negative_Correlation	MESH:C027576	MESH:D000077487
32540990	Negative_Correlation	MESH:D000077487	MESH:D009461
32540990	Association	MESH:D028361	24451
32540990	Negative_Correlation	MESH:D000077487	MESH:D017382
32540990	Positive_Correlation	MESH:D000077487	24451

